1
|
Rager EL, Bridgeford EP and Ollila DW:
Cutaneous melanoma: Update on prevention, screening, diagnosis, and
treatment. Am Fam Physician. 72:269–276. 2005.PubMed/NCBI
|
2
|
Linos E, Swetter SM, Cockburn MG, Colditz
GA and Clarke CA: Increasing burden of melanoma in the United
States. J Invest Dermatol. 129:1666–1674. 2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Chang AE, Karnell LH and Menck HR: The
National Cancer Data Base report on cutaneous and noncutaneous
melanoma: a summary of 84,836 cases from the past decade. The
American College of Surgeons Commission on Cancer and the American
Cancer Society. Cancer. 83:1664–1678. 1998. View Article : Google Scholar
|
4
|
Capizzi P and Donohue J: Metastatic
melanoma of the gastrointestinal tract: a review of the literature.
Compr Ther. 20:20–23. 1994.PubMed/NCBI
|
5
|
Poos HPAM, Kruijff S, Bastiaannet E, Van
Ginker RJ and Hoekstra HJ: Therapeutic groin dissection for
melanoma: Risk factors for short term morbidity. Eur J Surg Oncol.
35:877–883. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Yamaguchi T, Shionki Y, Koide K and
Kurioka H: A case of primary malignant melanoma of the esophagus
and analysis of 193 patients in Japan. Nippon Shokakibyo Gnkkal
Zasshi. 101:1087–1094. 2004.PubMed/NCBI
|
7
|
Karuppiah SV and Buchan KG: Primary
malignant melanoma: a rare cause of mediastinal mass. Jpn J Thorac
Cardiovasc Surg. 54:396–398. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lau CL, Bentley RC, Gockerman JP, Que LG
and D'Amico TA: Malignant melanoma presenting as a mediastinal
mass. Ann Thorac Surg. 67:851–852. 1999. View Article : Google Scholar : PubMed/NCBI
|
9
|
Shishido M, Nagao N and Miyamoto K:
Mediastinal amelanotic melanoma presenting as superior vena cava
syndrome. Nihon Kyobu Shikkan Gakkai Zasshi (Japanese Journal of
Thoracic). 35:240–244. 1997.PubMed/NCBI
|
10
|
Lemke AJ, Hosten N, Bornfeld N, et al:
Uveal melanoma: correlation of histopathologic and radiologic
findings by using thin-section MR imaging with a surface coil.
Radiology. 210:775–783. 1999. View Article : Google Scholar : PubMed/NCBI
|
11
|
Isiklar I, Leeds NE, Fuller GN and Kumar
AJ: Intracranial metastatic melanoma: correlation between MR
imaging characteristics and melanin content. AJR Am J Roentgenol.
165:1503–1512. 1995. View Article : Google Scholar : PubMed/NCBI
|
12
|
Escott EJ: A variety of appearances of
malignant melanoma in the head: A review. Radiographics.
21:625–639. 2001. View Article : Google Scholar : PubMed/NCBI
|
13
|
Wenig BM: Laryngeal mucosal malignant
melanoma: a clinicopathologic, immunohistochemical, and
ultrastructural study of four patients and a review of the
literature. Cancer. 75:1568–1577. 1995. View Article : Google Scholar
|
14
|
Chute DJ, Cousar JB and Mills SE:
Anorectal malignant melanoma morphologic and immunohistochemical
features. Am J Clin Pathol. 126:93–100. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Jungbluth AA, Busam KJ, Cerald WL, et al:
A103: An anti-melan-a monoclonal antibody for the detection of
malignant melanoma in paraffin-embedded tissues. Am J Surg Pat hol.
22:595–602. 1998. View Article : Google Scholar : PubMed/NCBI
|
16
|
Busm KJ, Chen YT, Old LJ, et al:
Expression of melan-A (MART1) in benign melanocytic nevi and
primary cutaneous malignant melancma. Am J Surg Pathol. 22:976–982.
1998. View Article : Google Scholar : PubMed/NCBI
|
17
|
Busam KJ, Iversen K, Coplan KC and
Jungbluth AA: Analysis of microphthalmiat ranscription factor
expression in normal tissues and tumors, and comparison of it s
expression with S-100 protein, gp100, and tyrosinase in
desmorlastic malignant melanoma. Am J Surg Pathol. 25:197–204.
2001. View Article : Google Scholar : PubMed/NCBI
|
18
|
De-Vries TJ, Smeets M, de-Graaf R and
Hou-Jensen K: Expression of gp100, MART-1, tyrosinase, and S100 in
paraffin-embedd primary melanomas and locoregional, lymph node, and
visceral metastases: implications for diagnosis and immunotherapy.
A study conducted by the EORTC Melanoma Cooperative Group. J
Pathol. 193:13–20. 2001. View Article : Google Scholar
|
19
|
Greco CS, Soffietti R, Bradac GB and
Boldorini R: Primitive cerebral melanoma: case report and review of
the literature. Surg Neurol. 55:163–168. 2001. View Article : Google Scholar : PubMed/NCBI
|
20
|
Lack EE, Kim H and Reed K: Pigmented
(‘black’) extraadrenal paraganglioma. Am J Surg Pathol. 22:265–269.
1998.
|
21
|
Moran CA, Albores-Saaverda J, Wenig BM and
Mena H: Pigmented extraadrenal papraganglions. A clinicopathologic
and immunohistochemical study of five cases. Cancer. 79:398–402.
1997. View Article : Google Scholar : PubMed/NCBI
|
22
|
Marco V, Sirvent J, Alvarez Moro J, Clavel
M, Muntal MT and Bauza A: Malignant melanotic schwannoma
fine-needle aspiration biopsy findings. Diagn Cytopathol.
18:284–286. 1998. View Article : Google Scholar : PubMed/NCBI
|
23
|
Matsumine A, Kusuzaki K, Nakamura T, et
al: Differentiation between neurofibromas and malignant peripheral
nerve sheath tumors in neuro-fibromatosis 1 evaluated by MRI. J
Cancer Res Clin Oncol. 135:891–900. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Li CS, Huang GS, Wu HD, et al:
Differentiation of soft tissue benign and malignant peripheral
nerve sheath tumors with magnetic resonance imaging. Clin Imaging.
32:121–127. 2008. View Article : Google Scholar : PubMed/NCBI
|
25
|
Stoll G, Bendszus M, Perez J and Pham M:
Magnetic resonance imaging of the peripheral nervous system. J
Neurol. 256:1043–1051. 2009. View Article : Google Scholar
|
26
|
Vlodavsky E, Ben-Izhak O, Best LA and
Kerner H: Primary Malignant Melanoma of the Anterior Mediastinum in
a Child. Am J Surg Pathol. 24:747–749. 2000. View Article : Google Scholar : PubMed/NCBI
|
27
|
Garbe C, Eigentler T, Keilholz U,
Hauschild A and Kirkwood J: Systematic Review of Medical Treatment
in Melanoma: Current Status and Future Prospects. Oncologist.
16:5–24. 2011. View Article : Google Scholar : PubMed/NCBI
|
28
|
Ko JM and Fisher DE: A new era: melanoma
genetics and therapeutics. J Pathol. 223:241–250. 2011.PubMed/NCBI
|
29
|
Kim CJ, Dessureault S, Gabrilovich D,
Reintgen DS and Slingluff CL: Immunotherapy for melanoma. Cancer
Control. 9:22–30. 2010.
|
30
|
Sivendran S, Glodny B, Pan M, Merad M and
Saenger Y: Melanoma immunotherapy. Mt Sinai J Med. 77:620–642.
2010. View Article : Google Scholar
|
31
|
Schuchter LM, Green R and Fraker D:
Primary and metastatic diseases in malignant melanoma of the
gastrointestinal tract. Curr Opin Oncol. 12:181–185. 2000.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Kim W, Baek JM, Suh YJ, Jeon HM and Kim
JA: Ileal malignant melanoma presenting as a mass with aneurysmal
dilatation: a case report. J Korean Med Sci. 19:297–301. 2004.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Berger AC, Buell JF, Venzon D, Baker AR
and Libutti SK: Management of symptomatic malignant melanoma of the
gastrointestinal tract. Ann Surg Oncol. 6:155–160. 1998. View Article : Google Scholar : PubMed/NCBI
|